Agenda

1:00 - 2:00 PM EST

Keynote

The Impact of Technology in Today’s Clinical Trial Ecosystem

Accelerating clinical trial timelines, managing costs, and faster time to patient is the holy grail of clinical research. Join Ken Getz, Research Professor, Tufts University School of Medicine, for our opening keynote that explores the state of clinical trials today and the impact of technology solutions on the clinical trial operating environment.

Ken Getz
Executive Director
Tufts Center for the Study of Drug Development

2:00 - 2:30 PM EST

Session

Ensuring Seamless Collaboration Throughout Drug Discovery

Collaborating with external partners is crucial in the biopharmaceutical industry and can create challenges in managing data, maintaining security, and complying with regulations. Dr. Rebecca Carazza will share how Nimbus Therapeutics leveraged data governance as a foundation to collaborate with its partners and maintain data integrity in working across its partner network.

Rebecca Carazza
Executive Director, Head of Information Systems
Nimbus Therapeutics

2:50 - 3:20 PM ET

Session

Streamlining Clinical Data Management: Harnessing the Cloud for Biotech Breakthroughs

Robust security, compliance, and governance controls are critical to scaling and simplifying modern clinical data platforms. Join Jon Weiss on an insightful journey on how Egnyte can provide a cloud-native multilingual platform to enable a cutting-edge approach to statistical analysis of clinical data.

Jon Weiss
Partner and Chief Innovator
Basis Digital Biotech

3:20 - 3:50 PM ET

Session

Underscoring the Importance of Data Governance in Clinical Development Technology

Data governance is vital in the life sciences industry, particularly concerning Electronic Document Management Systems (EDMS), Electronic Trial Master File (eTMF), Clinical Study Reports, and Statistics. Without standardized governance practices, we risk amplifying disorganized and unreliable data. Join Karen Travers and Mike Lynch, Halloran experts, as they share their experience of how governance frameworks are essential for maintaining data integrity and regulatory compliance across the clinical development lifecycle.

Mike Lynch
Senior Specialist
Halloran
Karen Travers
Principal
Halloran

3:50 - 4:40 PM ET

Panel Discussion

Impact of AI in R&D

AI is a hot topic in biotech, but how much is real and how much is fantasy? Join experts from Digitalis Ventures, Alnylam and Xilio as they discuss how AI is changing Clinical Research today and how to prepare for tomorrow.

Murtaza Cherawala
Senior Director of Data Management and Artificial Intelligence
Alnylam Pharmaceuticals
Jacob Oppenheim
Entrepreneur in Residence
Digitalis Ventures
Nate McBride
Senior Vice President of IT
Xilio
Cat Hall
Head of GXP Quality Assurance
Egnyte

5:00 - 5:30 PM ET

Session

Ask the Experts

Join several of our speakers and Egnyte’s Life Sciences Leaders as they respond to audience questions, trends in the industry and future innovation.

Rebecca Carazza
Executive Director, Head of Information Systems
Nimbus Therapeutics
Nate McBride
Senior Vice President of IT
Xilio
Ken Getz
Executive Director
Tufts Center for the Study of Drug Development
Greg Neustaetter
Vice President, Products
Egnyte

Get Started with Egnyte Today